← Leaderboards
Audra Iness
Virginia Commonwealth University
$116,641
Attributed
$116,641
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $35.9K · FY2018–21$50K$37.5K$25K$12.5K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$116,641 · 1
By mechanism
F30$116,641 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Larisa Litovchick$3,327,925
- Karen M Kester$1,699,523
- Shijian Chu$273,460
- Gordon D Ginder$21,192,432
- Sarah Elizabeth Golding$618,238
Others in their field
Other Emerging Leaders on “Binding Sites”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- John Damon Chodera · Sloan-Kettering Inst Can Research$18,444,289
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$11,907,032
- Kevin Wiehe · Duke University$11,369,637
Research focus
Binding SitesBioinformaticsBiological MarkersB-Myb ProteinCancer CellCdc GenesCell BehaviorCell CycleCell Cycle ArrestCell Cycle DeregulationCell Cycle ProgressionCell ProliferationCellsClinical BiomarkersComplexCuesCyclin-Dependent KinasesDreamsEpithelial CellsEquilibriumEvaluationFlow CytometryFutureBinding
Grant awards (4)
Mechanisms of B-Myb oncogenicity in ovarian cancer$10,585
F30 · FY2021 · CA · contact PI
Mechanisms of B-Myb oncogenicity in ovarian cancer$35,852
F30 · FY2020 · CA · contact PI
Mechanisms of B-Myb oncogenicity in ovarian cancer$35,348
F30 · FY2019 · CA · contact PI
Mechanisms of B-Myb oncogenicity in ovarian cancer$34,856
F30 · FY2018 · CA · contact PI